Stock

IN8bio, Inc. INAB

$1.24+0.00%

All stocks Create account to unlock

Overview

INAB market data

Price History

INAB price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for INAB. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

7 captured

12 Health Care Stocks Moving In Thursday's After-Market Session · Jul 23, 2026, 9:10 PM

IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma · Jul 9, 2026, 12:15 PM

IN8bio Announces Publication Of Peer-Reviewed Clinical Data From Phase 1 Trial Of INB-200 In The Journal Of Clinical Oncology · Jul 9, 2026, 12:10 PM

IN8bio Announced Updated Clinical Data Showing Improved Survival Data For Phase 1 INB-200 And Phase 2 INB-400 Studies At ASCO Annual Meeting May 29 - June 2 · Jun 1, 2026, 12:33 PM

8-K filing — IN8BIO, INC. (INAB) · Jun 1, 2026, 10:56 AM

IN8bio Presents New Translational Data Of Its DeltEx DRI Platform At ISCT 2026 Annual Meeting And ASGCT 2026 Annual Meeting · May 14, 2026, 12:08 PM

IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences · May 6, 2026, 12:10 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock